AXR-270

· AxeroVision, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXR-270, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction [Phase 2]

See pricing